Skip to main content

Day: August 10, 2022

Immunocore Reports Second Quarter 2022 Financial Results and Provides Business Update

Immunocore Reports Second Quarter 2022 Financial Results and Provides Business Update KIMMTRAK® (tebentafusp) now approved in over 30 countries with commercial launches underway in U.S. and Germany, and paid access in France Net KIMMTRAK / tebentafusp revenues of £27.7 million ($33.7 million) in Q2 2022 Transitioned all patients in Germany early access program to commercial supply in May of 2022 Protocol finalized for randomized Phase 2/3 trial of tebentafusp in advanced melanoma with first patient randomized planned for Q4 2022 Initial Phase 1 data from IMC-F106C, first PRAME x CD3 ImmTAC bispecific, accepted for oral presentation at ESMO Congress 2022 on September 9th Cash and cash equivalents of £208 million ($253 million) as of June 30, 2022. Subsequently raised £117 million ($140 million) of PIPE proceeds in July Conference call today,...

Continue reading

Aura Announces Second Quarter 2022 Financial and Operational Results and 2022 Guidance Update

ROAD TOWN, British Virgin Islands, Aug. 10, 2022 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (“Aura” or the “Company”) announces that it has filed unaudited consolidated financial statements and management discussion and analysis (together, “Financial and Operational Results”) for the period ended June 30, 2022 (“Q2 2022”) and 2022 Guidance Update (“Guidance”). The full version of the Financial and Operational Results and the Guidance can be viewed on the Company’s website at www.auraminerals.com or on SEDAR at www.sedar.com. All amounts are in U.S. dollars unless stated otherwise. Q2 2022 Highlights (Compared to Q2 2021):Consolidated quarterly production of 55,645 of gold equivalent ounces (“GEO1”) in Q2 2022 and 121,175 GEO for the first half of 2022. Production is now expected to be in the range of between...

Continue reading

Centerra Gold Reports Second Quarter Results

Mount Milligan Q2 cash provided by mine operations ($ millions) Mount Milligan Q2 cash provided by mine operations ($ millions)Mount Milligan Q2 All-in sustaining costs on a by-product basis per ounce(NG) ($/oz) Mount Milligan Q2 All-in sustaining costs on a by-product basis per ounce(NG) ($/oz)Mount Milligan YTD cash provided by mine operations ($ millions) Mount Milligan YTD cash provided by mine operations ($ millions)Mount Milligan YTD All-in sustaining costs on a by-product basis per ounce(NG) ($/oz) Mount Milligan YTD All-in sustaining costs on a by-product basis per ounce(NG) ($/oz)Öksüt Mine Q2 cash (used in) provided by mine operations ($ millions) Öksüt Mine Q2 cash (used in) provided by mine operations ($ millions)Oksut Mine YTD cash provided by mine operations ($ millions) Oksut Mine YTD cash provided by mine...

Continue reading

Gravity Reports Second Quarter of 2022 Results and Business Update

Seoul, Korea, Aug. 10, 2022 (GLOBE NEWSWIRE) — GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile games based in South Korea, today announced its unaudited financial results for the second quarter ended June 30, 2022, prepared in accordance with international Financial Reporting Standards as issued by the International Accounting Standards Board and business updates. SECOND QUARTER 2022 HIGHLIGHTSTotal revenues were KRW 96,519 million (US$ 74,305 thousand), representing an 8.9% increase from the first quarter ended March 31, 2022 (“QoQ”) and a 15.4% increase from the second quarter ended June 30, 2021 (“YoY”). Operating profit was KRW 22,115 million (US$ 17,025 thousand), representing a 0.9% decrease QoQ and a 15.4% increase YoY. Profit before income tax expenses was KRW...

Continue reading

HSBC Bank Plc – Form 8.5 (EPT/RI) – RPS GROUP PLC

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITYRule 8.5 of the Takeover Code (the “Code”) 1.         KEY INFORMATION(a) Name of exempt principal trader: HSBC Bank Plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates:     Use a separate form for each offeror/offeree RPS GROUP PLC(c) Name of the party to the offer with which exempt principal trader is connected: Offerer – WSP Group Holdings Limited(d) Date dealing undertaken: 09 August 2022(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?     If it is a cash offer or possible cash offer, state “N/A” N/A2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER Where...

Continue reading

H1 2022 in line with expectations – Annual Recurring Revenue growth of 45 %

Company announcement no 13-2022 Søborg, August 10, 2022 Financial report for the period January 1 to June 30, 2022 The H1 2022 results were in line with expectations. Annual Recurring Revenue (ARR) amounted to DKK 15.6m corresponding to an annual growth of 45%. The SaaS metrics improved compared to Q1 2022, with a growth in ARR of DKK 1.3m up from DKK 0.7m for Q1 2022. Konsolidator is actively seeking to raise DKK 20-25m in further equity capital to restore the negative equity and secure financing for the current 2022-24 strategy, Unfolding the potential. “Q2 2022 showed good progress especially the Nordics really excelled, and the upsale to current customers also developed positively. We remain confident that Konsolidator has a good market fit in the UK. However, the market penetration takes longer than expected. We are actively seeking...

Continue reading

Point of Care Diagnostics Market Rise at 5.2% CAGR [2022-2029] Size, Growth, Industry Share, Future Trends, Research Report, Opportunities and Challenges

Point of Care Diagnostics Market Size is projected to grow from USD 36.37 billion in 2022 to USD 51.94 billion by 2029, at CAGR of 5.2% during forecast period, Increasing Focus on Introduction of Advanced POC Kits to Stoke Demand: Fortune Business Insights™ Pune, India, Aug. 10, 2022 (GLOBE NEWSWIRE) — The Global point of care diagnostics market Size is projected to grow during the forecast period due to the increasing incidences of infectious and chronic diseases. Fortune Business Insights™ publishes this information in a report titled, Point of Care Diagnostics Market 2029. As per the report, the point of care diagnostics market size was valued at USD 46.65 billion in 2021. The market size is expected to rise from USD 36.37 billion in 2022 to USD 51.94 billion by 2029 at a CAGR of 5.2% during the projected period. Key Industry...

Continue reading

Dermal Fillers Market with 7.4% CAGR 2022-2029, Leading Players, Geographical Segmentation, Development, Dynamics, Future Trends, Size, Opportunities, Challenges

According to Fortune Business Insights, the global Dermal Fillers Market size is projected to grow from USD 5.31 Billion in 2022 to USD 8.74 billion in 2029, Increasing Adoption of Painless Facial Treatment to Augment Market Growth Pune, India, Aug. 10, 2022 (GLOBE NEWSWIRE) — The global dermal fillers market size is expected to gain momentum by reaching USD 8.74 billion by 2029 while exhibiting an impressive CAGR of 7.4% between 2022 to 2029. In its report titled “Dermal Fillers Market, 2022-2029,” Fortune Business Insights mentions that the market stood at USD 5.31 billion in 2022. Industry DevelopmentMarch 2021 – Galderma announced the re-launch of Sculptra (injectable poly-l-lactic acid) in Europe with an updated administration protocol.Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dermal-fillers-market-100939Report...

Continue reading

Rule 8.3 – EMIS Group PLC

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1.        KEY INFORMATION  (a)        Full name of discloser: Investec Wealth & Investment Limited(b)        Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A(c)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offereeEmis Group Plc(d)        If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)        Date...

Continue reading

The Subscription Period of Valoe’s Convertible Bond 1/2022 Has Been Discontinued. The Result of the Convertible Bond 1/2022.

Valoe Corporation                Stock Exchange Release 10 August 2022 at 12.55 Finnish time                                  The Board of Directors of Valoe Corporation (“Company”) has resolved to discontinue the subscription period of the Convertible Bond 1/2022 disclosed on 26 April 2022, and the Convertible Bond 1/2022 can no longer be subscribed. The Convertible Bond 1/2022 was subscribed for a total of EUR 0.7 million. The subscriptions were made in new cash investments. The Board of Directors of the Company has approved the subscriptions. One loan share of EUR 100,000 pursuant to the Promissory Note entitles the Promissory Note Holder to subscribe for 1,428,571 new shares or treasury shares held by the Company. Based on the subscriptions made pursuant to the loan shares Valoe shall issue a maximum amount of 10,000,000 new Valoe...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.